– Nielsen, Advanced Neuromodulation Systems, Medtronic, Microsoft and Brainlab emerge as leading IP holders
San Francisco, CA– (May 6, 2015) – SharpBrains, the leading market research firm tracking applied neuroscience, unveiled today–at the 2015 NeuroGaming Summit–a new 206-page report that, for the first time, analyzes the major intellectual property trends in the Pervasive Neurotechnology industry: non-invasive, potentially ubiquitous neurotechnologies, commercially viable outside major medical institutions or research facilities.
“Through this report’s wide and deep analysis, SharpBrains has made another key contribution to our understanding of the tools and technologies that are at the forefront of the global neurotechnology industry, and at the forefront of technology overall,” highlights Zack Lynch, Executive Director and Founder of the Neurotechnology Industry Organization.
Over the past two years a SharpBrains team, crossing the silos of science, intellectual property, technology and business, first identified and then analyzed more than 10,000 patent filings to capture the core themes of a game-changing industry: Pervasive Neurotechnology. Technology, rooted in neuroscience, non-invasive and potentially ubiquitous, designed to monitor brain activity, to change it and to interface the brain with a wide range of medical, industrial, consumer and computational applications, building on technologies such as electroencephalography (EEG and qEEG), neuro-monitoring, neurocognitive training, transcranial stimulation (TMS and tCDS), virtual reality and more.
“Neurotechnology, our analysis reveals, is going to become pervasive within and beyond the medical domain,” said Alvaro Fernandez, the report’s Editor-In-Chief. “The number of patent filings in the space is growing at unprecedented rates, and we are proud to offer this unique window into the future for executives, entrepreneurs, researchers, and developers at the forefront of innovation.”
An infographic, available HERE, summarizes key findings of the report, titled Pervasive Neurotechnology: A Groundbreaking Analysis of 10,000+ Patent Filings Transforming Medicine, Health, Entertainment and Business.
“All too often, neuroscience has been siloed in academia and medical centers, largely absent from mainstream innovation processes. The opportunity with #PervasiveNeurotech is to gain a seat at the big table, to contribute to the future of the digital revolution and human progress,” adds Olivier Oullier, PhD, Professor of Behavioral and Brain Sciences at Aix-Marseille University.
Leading 30 Holders of Pervasive Neurotechnology Intellectual Property:
To identify key patents and leading IP holders, the SharpBrains team developed a proprietary IP Strength Index, combining quantitative and qualitative criteria. As a result of which, these are the Leading 30 IP Holders in the industry:
- Nielsen (NYSE:NLSN)
- Advanced Neuromodulation Systems
- Medtronic (NYSE:MDT)
- Microsoft (NASDAQ:MSFT)
- Posit Science
- BodyMedia (Jawbone)
- Accenture (NYSE:ACN)
- General Electric (NYSE:GE)
- Lumos Labs
- IBM (NYSE:IBM)
- Scientific Learning (OTCMKTS:SCIL)
- McLean Hospital Corp
- Health Hero Network (Bosch)
- Philips (NYSE:PHG)
- New York University
- Sedline (Masimo NASDAQ:MASI)
- CNS Response (OTCMKTS:CNSO)
- Compumedics (ASX:CMP)
- Stanford University
- Invention Science Fund
- Brain.com / Braintainment
- Advanced Brain Monitoring
- Natus Medical (NASDAQ:BABY)
- Lifewatch Tech (SWX:LIFE)
To learn more about the report, visit https://sharpbrains.com/pervasive-neurotechnology/